Patients with sleep apnea who are intolerant of traditional therapy such as CPAP or those who have failed other treatment modalities may be candidates for the Inspire hypoglossal nerve stimulator. This device is similar to a pacemaker. A device is implanted in the chest that detects pauses in breathing and provides stimulation to the tongue muscle, preventing it from falling back and blocking the air passage. This device has been approved by the FDA and thousands of patients have undergone this surgery around the world. St. Joseph Mercy Health System is one of three hospitals in the Michigan performing this surgery. In order to be a candidate, patients must have body mass index (BMI) of 32 or less and have moderate to severe sleep apnea. In addition, patients considering this procedure will need to undergo a sleep endoscopy (DISE) to establish candidacy. The inspire device has cure rates of over 50% with more than 70% of patients able to discontinue CPAP. Snoring resolves in over 85% of patients. Better yet, 85% of patients continue to use the device after 3 years. For more information, go to https://www.inspiresleep.com.